HEIDELBERG PHARMA AG (HPHA.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:HPHA - DE000A11QVV0 - Common Stock
2.71 EUR
+0.21 (+8.4%)
| TTM (2025-8-31) | 2024 (2024-11-30) | 2023 (2023-11-30) | 2022 (2022-11-30) | 2021 (2021-11-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.04M | 6.85M | 9.86M | 18.51M | 1.75M | |||
| Cost Of Goods | 466.00K | 1.78M | 3.25M | 4.68M | 4.71M | |||
| Gross Profit | 2.57M | 5.07M | 6.61M | 13.83M | -2.96M | |||
| Operating Expenses | 29.76M | 28.92M | 27.91M | 32.09M | 22.97M | |||
| Research and Development | 27.24M | 21.84M | 28.07M | 26.38M | 18.75M | |||
| Selling, General, and Administrative Expenses | 7.00M | 6.74M | 5.25M | 4.82M | 3.99M | |||
| Operating Income | -27.19M | -23.85M | -21.30M | -18.26M | -25.93M | |||
| Interest Income/Expense | 1.01M | 1.65M | 869.30K | 358.30K | -504.60K | |||
| Other Income/Expense | N/A | 0.00 | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 2.82M | 86.00K | 115.00K | 300.00K | |||
| Income Before Taxes | -26.18M | -19.38M | -20.35M | -17.79M | -26.14M | |||
| Income Tax | N/A | 0.00 | 0.00 | 1.92M | 0.00 | |||
| Net Income | -26.18M | -19.38M | -20.35M | -19.70M | -26.14M | |||
| EBITDA | -26.32M | -22.98M | -20.42M | -17.50M | -25.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.56 | -0.42 | -0.44 | -0.53 | -0.80 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 84.66% | 74.00% | 67.01% | 74.73% | -169.29% | |||
| Profit Margin | -861.84% | -282.98% | -206.38% | -106.42% | -1493.81% | |||
| Operating Profit Margin | -895.13% | -348.23% | -216.07% | -98.63% | -1482.12% | |||
All data in EUR